Chaim Lebovits and Rasheda Ali Discuss Brainstorm Breakthrough

Chaim Lebovits, CEO and president of BrainStorm Cell Therapeutics in Israel, discusses the potential for the company’s developmental therapy and its implications for patients with ALS. He is joined in this segment by Rasheda Ali, daughter of Muhammad Ali, and an advisory board member for BrainStorm.

Categories: Research News, Technology, Treatments  |  Tags: ALS, ALS community, ALS research, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, BrainStorm Cell Therapeutics, Chaim Lebovits, Hadassah Medical Center, Lou Gehrig's disease, Massachusetts General Hospital, Muhammad Ali, NurOwn, RASCALS Foundation, Rasheda Ali, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis  |  No comments